Max Marchione predicts most people will take a therapeutic compound within 10 years
He points to GLP-1s as proof, citing his figure that 1 in 9 American adults now use one for weight loss.
Recap by typeshit. Post by Max Marchione on X.
He points to GLP-1s as proof, citing his figure that 1 in 9 American adults now use one for weight loss.
Recap by typeshit. Post by Max Marchione on X.
The 52-year-old actor points to his early 4am workouts and discipline instead of weight loss shots. A celebrity opinion, not new data.
Metz says the drug improved her mobility enough to handle eight Broadway shows a week in "& Juliet". Her account, not a clinical claim.
A general piece on how GLP-1 drugs like Ozempic and Wegovy reshaped weight management in the US. Light on new details.
The broker says Laurus beat 2QFY27 estimates on EBITDA and profit, with its CDMO pipeline and peptide work driving the higher forecasts.
Obesity specialist Dr. Alexandra Sowa says long-term use makes cost the flashpoint, as insurers and employers scale back coverage and Medicare benefits face a 2027 question.
She compares GLP-1 drugs to laser eye surgery, epidurals and dishwashers, tools nobody calls cheating, in a blunt social post.
Loading…